With ties to Colorado State University Fort Collins, KromaTiD is organized around advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents. The firm is developing a method and kit using chromatid paints to detect chromosomal inversions. Small chromosome inversions are virtually invisible using the cytogenetic methods currently in use. KromaTiD's molecular cytogenetic and GeneTracker® assays discover, detect and diagnose the widest range of disease causing mutations - including inversions and translocations - in a single test. Based on Directional Genomic Hybridization (dGH), KromaTiD's assays generate sequence, location and orientation data from single cells, making them ideal for mixed cell population studies.
